国家基本药物遴选引入药物经济学评价方法的探讨

Introduction of Pharmacoeconomic Evaluation into the Selection of National Essential Drugs

目的:探讨在国家基本药物遴选中引入药物经济学评价方法,以提高基本药物的可及性、可支付性。方法:介绍药物经济学评价方法在国内、外基本药物遴选中的应用状况,分析在我国面临的主要问题。结果与结论:我国基本药物遴选引入药物经济学评价方法面临的主要问题是评价机构及其专业人才缺乏、技术标准不统一、制度保障不完善。提出了在我国基本药物遴选过程中引入药物经济学评价方法的五点思路。

OBJECTIVE： To introduce the pharmacoeconomic evaluation into the selection of national essential drugs so as to improve the accessibility of drugs, use essential drugs rationally, and control the rapid increase of drug expenses. METHODS： The status quo of the application of pharmacoeconomic evaluation in the selection process of essential drugs in both China and abroad and the main problems faced by China were analyzed. RESULTS ＆ CONCLUSION ： The lack of evaluation agency and professional talents, non - unified technical standard and imperfect system guarantee are the main problems faced by China in the introduction of pharmaeoeconomic evaluation into the selection of national essential drugs were, thus 5 thoughts on the introduction of pharmacoeeonomic evaluation into the selection of National Essential Drugs have been put forward.